Loading clinical trials...
Loading clinical trials...
A Pilot Study on the Immunopathogenesis of Bone Disease in Older HIV-infected Adults
This study will look to see if there are changes in the blood cells that are associated with bone disease and sort out effects that are due to the HIV virus itself, the medications and see if faster aging occurs in the cells of HIV infected persons. Bone disease will be measured by a special X-ray called a DEXA scan. A DEXA scan is used by doctors to see if someone has normal bone mass for their age or if there is thinning of the bones. The purposes of this study are: * to learn how common bone disease is in HIV infected patients over the age of 50 years that receive their care at the CORE Center * to see what are the common causes of bone disease in older HIV infected persons * to see if there are differences in blood cells and levels of cytokines in patients who do or do not have bone disease, as this may help researchers determine the cause of bone disease.
Age
50 - 70 years
Sex
ALL
Healthy Volunteers
No
Ruth M Rothstein CORE Center
Chicago, Illinois, United States
Start Date
December 1, 2009
Primary Completion Date
February 1, 2011
Completion Date
February 1, 2011
Last Updated
August 3, 2012
101
ACTUAL participants
Lead Sponsor
Ruth M. Rothstein CORE Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06694805